SCHEMBL1409

SCHEMBL1409

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3O)nc12

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.78
PDE3B Q13370 3/20 0.78
PDE3A Q14432 3/20 0.78
ABCC4 O15439 2/20 0.78
PDE2A O00408 1/20 0.78
ABCC5 O15440 1/20 0.78
PDE6D O43924 1/20 0.78
PDE8A O60658 1/20 0.78
PDE9A O76083 1/20 0.78
ABCB11 O95342 1/20 0.78
CYP3A4 P08684 1/20 0.78
HTR1A P08908 1/20 0.78
PDE6A P16499 1/20 0.78
PDE6G P18545 1/20 0.78
PDE4A P27815 1/20 0.78
ADORA2A P29274 1/20 0.78
ADORA1 P30542 1/20 0.78
ADRA1A P35348 1/20 0.78
PDE6B P35913 1/20 0.78
PDE6C P51160 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30848766 1.00 PDE5A (0.78) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL6208588 0.90 PDE5A (0.79) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL2615083 0.90 PDE5A (0.79) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL2615082 0.90 PDE5A (0.79) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL28478988 0.90 PDE5A (0.79) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL12317717 0.89 PDE5A (0.74) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL6207658 0.88 PDE5A (0.86) PDE5APDE3BPDE3AABCC4PDE2A
Sildenafil SCHEMBL5683880 0.87 PDE5A (1.00) PDE5APDE3BPDE3AABCC4PDE2A
Sildenafil SCHEMBL29361663 0.87 PDE5A (1.00) PDE5APDE3BPDE3AABCC4PDE2A
Sildenafil SCHEMBL1895 0.87 PDE5A (1.00) PDE5APDE3BPDE3AABCC4PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111732593-A Piperazine oxide derivative and composition, preparation method and application thereof 黄泳华 2020-10-02 CN claimed
CN-111732593-A Piperazine oxide derivative and composition, preparation method and application thereof 黄泳华 2020-10-02 CN disclosed
EP-2366393-A2 Roflumilast for the treatment of pulmonary hypertension Nycomed GmbH (DE) 2011-09-21 EP disclosed
EP-2024369-A2 NOVEL PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE Matrix Laboratories Ltd (IN) 2009-02-18 EP disclosed
WO-2007141805-A2 NOVEL PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE MATRIX LABORATORIES LIMITED (IN) 2007-12-13 WO disclosed
WO-2007113243-A2 USE OF PDE 5 INHIBITORS FOR THE TREATMENT OF OVERACTIVE BLADDER INVESTIGACIÓN Y CLÍNICA ANDROLÓGICAS S.L. (ES) 2007-10-11 WO disclosed
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
US-5719283-A INHIBITORS OF PHOSPHODIESTERASES; CARDIOVASCULAR DISORDERS PFIZER INC. (US) 1998-02-17 US disclosed
EP-0463756-B1 Pyrazolopyrimidinone antianginal agents PFIZER LTD (GB) 1995-04-19 EP disclosed
US-5346901-A Treatment of angina, hypertension, heart failure and atherosclerosis PFIZER INC. (US) 1994-09-13 US disclosed
US-5250534-A Inhibitors of cyclic guanosine 3*,5*-monophosphate phosphodiesterase PFIZER INC. (US) 1993-10-05 US disclosed
EP-0463756-A1 Pyrazolopyrimidinone antianginal agents Pfizer Limited (GB) 1992-01-02 EP disclosed